NJ Bio Welcomes Ilan Kaufthal as Senior Advisor and Pharmaceutical Executives, Ronald Gold, Steven Klosk, and Chetan Jain to its Board of Directors
Retrieved on:
Wednesday, August 25, 2021
Research, General Health, Pharmaceutical, Science, Marketing, Engineering, Chemicals, Plastics, Biotechnology, Communications, Manufacturing, Other Science, Health, Industry, Active ingredient, Columbia University Irving Medical Center, Drug development, Founder, Growth, Tronox, Chemistry, Leadership, Richard Roberts (pharmaceutical executive), Board of directors, API, Director, Founder CEO, CRO, IDB Bank, Multimedia, ROW, CDMO, Board, Permira, Senior advisor, East wind, COO, Irving Place Capital, CEO, Sale, Schroders, C & H, Caladrius Biosciences, Cambrex Corporation, GMP, ACET, Fine chemical, Management
NJ Biopharmaceuticals LLC (d/b/a NJ Bio), an expert provider of chemistry and biopharmaceutical services welcomed the appointments of Ilan Kaufthal as Senior Advisor, and Ronald Gold , Steven Klosk , and Chetan Jain to its Board of Directors.
Key Points:
- NJ Biopharmaceuticals LLC (d/b/a NJ Bio), an expert provider of chemistry and biopharmaceutical services welcomed the appointments of Ilan Kaufthal as Senior Advisor, and Ronald Gold , Steven Klosk , and Chetan Jain to its Board of Directors.
- View the full release here: https://www.businesswire.com/news/home/20210825005087/en/
NJ Bio Welcomes Ilan Kaufthal as Senior Advisor and Pharmaceutical Executives, Ronald Gold, Steven Klosk, and Chetan Jain to its Board of Directors (Photo: Business Wire)
We are excited to welcome Ilan, a seasoned investor, banker, and senior corporate executive to NJ Bio as our senior advisor. - We are confident that with Ilans financial acumen, NJ Bio will be able to grow into a powerhouse service provider, said Nareshkumar Jain , Ph.D., President and CEO of NJ Bio.
- NJ Bio has appointed three veteran pharmaceutical executives, Ron Gold, Steven Klosk, and Chetan Jain to its Board of Directors.